Do you need a prescription for compounded tirzepatide or semaglutide?
Yes. Compounded tirzepatide and semaglutide can only be dispensed on a prescription for an individual patient, written by a licensed clinician after an evaluation, and filled by a state-licensed 503A pharmacy. Sites that sell GLP-1s without a prescription, or as “research peptides”, are outside the law, and FDA has sent warning letters to sellers of unapproved semaglutide.
Released · Last reviewed · how we verify
Limitations of this answer
Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. This page reports prices and terms; whether any GLP-1 suits you is a decision for you and a licensed clinician.
Frequently asked
Do you need a prescription for compounded tirzepatide or semaglutide?
Yes. Compounded tirzepatide and semaglutide can only be dispensed on a prescription for an individual patient, written by a licensed clinician after an evaluation, and filled by a state-licensed 503A pharmacy. Sites that sell GLP-1s without a prescription, or as “research peptides”, are outside the law, and FDA has sent warning letters to sellers of unapproved semaglutide.
How current are the prices on TopGLP1Providers?
Every price on TopGLP1Providers carries the date it was read on the program’s own page; the whole dataset was re-read on November 20, 2026, from 2026-11-21 00:33 to 00:57 UTC, and NexLife’s plan pages were checked again for this site on November 21 (UTC). Programs whose pages refused automated reads that day, such as TrimRx, MEDVi, bmiMD, Embody, Ro and Hims & Hers, show no current price rather than an older one. When a program changes its price, the record, the pages that cite it and the changelog are updated together.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)